1,402
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Treatment with Tang-luo-ning altered the microRNA expression profile in rats with diabetic peripheral neuropathy

, , , , , , & ORCID Icon show all
Pages 841-851 | Received 26 May 2020, Accepted 11 Jul 2020, Published online: 27 Jul 2020

References

  • Li J, Hu X, Liang F, et al. Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-kappaB in diabetic peripheral neuropathy. Appl Biochem Biotechnol. 2019;189(4):1167–1182. .
  • Gao YB, Zhou H, Zhang TJ. Clinical research on patients of diabetic peripheral neuropathy treated with Tangluoning. China J Traditional Chin Med Pharm. 2013;28:1673–1677.
  • Zhang T, Gao Y, Gong Y, et al. Tang-luo-ning improves mitochondrial antioxidase activity in dorsal root ganglia of diabetic rats: a proteomics study. Biomed Res Int. 2017; 2017:1-7.
  • Zhang TJ, Gao YB, Zhou H. Effects of Chinese herbal compound prescription on the saccharide content of sciatic nerve in STZ induced diabetic rats. Beijing J Traditional Chin Med. 2011;30(5):394–396.
  • Zhang TJ, Gao YB, Zhou H. Effects of tangluoning on serum NGF levels and expression of NGF mRNA in sciatic nerve in STZ induced diabetic rats. Jiangsu J Traditional Chin Med. 2011;43(2):81–83.
  • Gao YB, Zhang T, Zhou H, et al. Influences of tangluoning oral solution on content of serum IGF-1 and gene expression of liver IGF-1 in rats with diabetes induced by STZ. J Beijing Univ Traditional Chi Med. 2009;32(7):454–459.
  • Zhang TJ, Gao YB, Zhou H. Influences of tangluoning oral solution on blood sugar and responses to cold and heat stimulations in rats with diabetes induced by STZ. J Beijing Univ Traditional Chin Med. 2009;16(2):6–9.
  • Zou D-W, Gao Y-B, Zhu Z-Y, et al. Traditional chinese medicine tang-luo-ning ameliorates sciatic nerve injuries in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2013;2013:989670.
  • Yang X, Yao W, Liu H, et al. Tangluoning, a traditional Chinese medicine, attenuates in vivo and in vitro diabetic peripheral neuropathy through modulation of PERK/Nrf2 pathway. Sci Rep. 2017;7(1):1014. .
  • Jiang Y, Zhu Y, Zhen T, et al. Transcriptomic analysis of the mechanisms of alleviating renal interstitial fibrosis using the traditional Chinese medicine Kangxianling in a rat model. Sci Rep. 2020;10(1):10682. .
  • Li L, Gong Z, Xue P, et al. Expression of miRNA-223 and NLRP3 gene in IgA patients and intervention of traditional Chinese medicine. Saudi J Biol Sci. 2020;27(6):1521–1526.
  • Bing W, Wei H. New target for anti-tumor research in traditional Chinese medicine—microRNA. Cancer Res Prev Treat. 2013;40(12):1200–1203.
  • Ziegler D, Strom A, Lobmann R, et al. High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). J Diabetes Complications. 2015;29(8):998–1002. .
  • Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American diabetes association. Diabetes Care. 2005;28(4):956–962. .
  • Pop-Busui R, Boulton AJM, Feldman EL, et al. diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care. 2017;40(1):136–154. .
  • Sinnreich M, Taylor BV, Dyck PJ. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist. 2005;11(2):63–79.
  • Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293. .
  • Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9(6):660–674.
  • Ma S, Yao S, Tian H, et al. Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/beta-catenin pathway. Lipids Health Dis. 2017;16(1):31. .
  • Yang X, Kou Y, Hu X, et al. The relationship between neural tube defects and Dishevelled genes expression. Chin J Birth Health Heredity. 2014;2014:1.
  • H, Hua R, An Y, et al. Expression of neurotrophic factors in therapy of bone marrow mesenchymal stem cells to newborn rats with severe hypoxic ischemic brain damage. Med J Chin Peoples Armed Police Forces. 2014;2014:693–697.
  • Song J, Lee S-T, Kang W, et al. Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett. 2007;423(1):58–61. .
  • Dong YZ, Zong HB, Yang L. Restoration of neurotrophin-3 on amyotrophy after injury of sciatic nerve in rats. J Xinxiang Med Coll. 2012;29(11):831–833.
  • Wang Z, Chen TB, Wang YF. Dendritic cell-induced neural stem cell survival via NT-3/TrkC signaling pathway. J Third Mill Med Univ. 2013;35(12):1181–1191.
  • Mackay CP, Kuys SS, Brauer SG. The effect of aerobic exercise on brain-derived neurotrophic factor in people with neurological disorders: a systematic review and meta-analysis. Neural Plast. 2017;2017:4716197.
  • Phillips C. Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plast. 2017;2017:7260130.
  • Duan X, Zhu T, Chen C, et al. Serum glial cell line-derived neurotrophic factor levels and postoperative cognitive dysfunction after surgery for rheumatic heart disease. J Thorac Cardiovasc Surg. 2018;155(3):958–965. e1. .
  • Fan PT, Zhou BY, Zhang LM. Neurotrophic factor and its role in neurodegenerative diseases. Chin J Neuroanat. 2018;34(2):278–282.
  • Yan YH, Li SH, Kong L. High expression of NT-3 promotes the differentiation of neural stem cells into cholinergic neurons. Chin Pharmacol Bull. 2016;32(5):631–637.
  • Lei ZW, Bo ZD, Hong GX. An experiment study on the repair of peripheral nerve injury by NT-3 gene modified neural stem cells. Chin J Exp Surg. 2005;22(1):80–82.
  • Wang XQ, Li XH. Brain-derived neurotrophic factor and diabetes. Pharm J Chin People’s Liberation Army. 2002;18(2):170–171.
  • Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med. 1999;107(2B):34S–42S.
  • Chen Q, Smith GM, Shine HD. Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp Neurol. 2008;209(2):497–509.